Reporting Quality-Of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

American Journal of Kidney Diseases - United Kingdom
doi 10.1053/j.ajkd.2015.09.033
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Quality of Life Reporting in Multiple Sclerosis Clinical Trials: Enough Quality?

Multiple Sclerosis
Neurology
2012English

Planning and Reporting of Quality-Of-Life Outcomes in Cancer Trials

Annals of Oncology
MedicineOncologyHematology
2015English

Reporting Quality of Abstracts in Phase III Clinical Trials of Systemic Therapy in Metastatic Solid Malignancies

Trials
MedicinePharmacology
2015English

Reporting of Quality of Life in Clinical Trials of Biologics for Plaque Psoriasis: A Systematic Review

SKIN The Journal of Cutaneous Medicine
2018English

Controlled Trials of Immunosuppressive Therapy in Hepatitis

Postgraduate Medical Journal
Medicine
1974English

Quality of Reporting in Randomized Trials

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2010English

Experience of Immunosuppressive Therapy in Partial Liver Transplantation.

Japanese Journal of Clinical Immunology
1991English

The Choice of Immunosuppressive Therapy Depending on the Level of Anti-Hla Antibodies in Kidney Transplantation

Transplantologiya
2018English

Reporting of Clinical Trials in Gut: The CONSORT Statement. Consolidated Standards of Reporting Trials.

Gut
Gastroenterology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy